HealthcareServices

Chemiluminescence Immunoassay Industry Anticipated to Expand at 8.6% CAGR During the Forecast Period

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Chemiluminescence Immunoassay Market From 2025 To 2034?

The chemiluminescence immunoassay market size has experienced robust growth in recent years. It is projected to expand from $13.63 billion in 2024 to $14.85 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.9%. The market’s historical expansion can be attributed to an elevated focus on high-sensitivity detection methods, greater integration with point-of-care testing devices, an increasing demand for multiplex assay capabilities, the expanded application of chemiluminescence in oncology diagnostics, and the rising prevalence of infectious diseases.

The chemiluminescence immunoassay market is projected to experience significant expansion over the next few years. Its value is expected to reach $20.64 billion by 2029, driven by a compound annual growth rate (CAGR) of 8.6%. This growth during the forecast period is attributed to several factors, including the increasing demand for personalized medicine, the rising adoption of digital health technologies, growing investments in healthcare infrastructure, the broadening applications in infectious disease diagnostics, and the expansion of automated central laboratory settings. Noteworthy trends predicted for this period encompass advancements in automated immunoassay platforms, the evolution of multiplex chemiluminescence immunoassay technologies, innovative point-of-care diagnostic solutions, the integration of AI for result interpretation, and the incorporation of chemiluminescence immunoassay into personalized medicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27252&type=smp

Which Factors And Drivers Are Influencing The Chemiluminescence Immunoassay Market In 2025?

The chemiluminescence immunoassay market is anticipated to expand due to the increasing incidence of infectious diseases. Infectious diseases are defined as conditions resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can transmit between individuals, either directly or indirectly. The rising occurrence of these diseases is linked to an increase in antimicrobial resistance, which makes standard treatments ineffective, thereby enabling infections to persist and spread. Chemiluminescence immunoassays are crucial for diagnosing infectious diseases, offering highly sensitive and specific detection of biomarkers, which facilitates the early and precise identification of pathogens. These assays also minimize diagnostic waiting times by yielding quick and dependable results, leading to better patient care and more effective treatment. For instance, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England reached 4,850 in 2023, marking a 10.7% increase from 4,380 cases in 2022. Consequently, the growing prevalence of infectious diseases is a key factor propelling the expansion of the chemiluminescence immunoassay market.

What Are The Primary Types Of Segments Analyzed In The Chemiluminescence Immunoassay Market?

The chemiluminescence immunoassay market covered in this report is segmented

1) By Product Type: Analyzers, Kits, Reagents

2) By Sample Type: Blood, Saliva, Urine, Other Samples

3) By Technology: Chemiluminescence Enzyme Technology (CLEIA), Electrochemiluminescence Immunoassay (ECLI), Microparticle Chemiluminescence Immunoassay

4) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease, Other Applications

5) By End-User: Hospitals, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End-Users

Subsegments:

1) By Analyzers: Fully Automated Analyzers, Semi Automated Analyzers, Portable Analyzers

2) By Kits: Detection Kits, Quantitative Kits, Qualitative Kits, Multiparameter Kits

3) By Reagents: Luminol Reagents, Isoluminol Reagents, Acridinium Ester Reagents, Other Reagents

What Are The Major Trends Driving The Growth Of The Chemiluminescence Immunoassay Market?

Major companies operating in the chemiluminescence immunoassay market are concentrating on developing advanced products, such as sophisticated chemiluminescence immunoassay analyzers, to improve test accuracy, increase throughput, and provide faster diagnostic results for a wide array of clinical applications. Chemiluminescence immunoassay analyzers are automated instruments that detect and measure light emitted during chemical reactions to precisely identify specific biomarkers in diagnostic tests. For instance, in July 2023, Fapon Biotech Inc., a China-based biotechnology company, introduced the Shine i8000/9000, a chemiluminescence immunoassay analyzer. This system is engineered for medium to large laboratories, delivering quick preliminary results within 10 minutes and high precision through its compact, stable, and user-friendly design. Key features encompass a 360-degree large-span display, one-touch bulk loading for reaction cups, a dual-tube backup substrate system, and automatic reaction cup disposal to minimize contamination. Its fully automated workflow lessens manual intervention, while advanced algorithms boost result consistency, making it well-suited for high-volume diagnostic settings.

Who Are The Major Companies Operating In The Chemiluminescence Immunoassay Market?

Major companies operating in the chemiluminescence immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Revvity Inc., DiaSorin S.p.A., Tecan Group Ltd., Euroimmun AG, Randox Laboratories Ltd., Autobio Diagnostics Co. Ltd., Wondfo Biotech Co. Ltd., Fujirebio Diagnostics Inc., Trivitron Healthcare Pvt. Ltd., Getein Biotech Inc., Fapon Biotech Inc., Diazyme Laboratories Inc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chemiluminescence-immunoassay-global-market-report

Which Region Currently Holds The Largest Share Of The Chemiluminescence Immunoassay Market?

North America was the largest region in the chemiluminescence immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemiluminescence immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chemiluminescence Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27252&type=smp

Browse Through More Reports Similar to the Global Chemiluminescence Immunoassay Market 2025, By The Business Research Company

Waterproof Adhesives And Sealants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/waterproof-adhesives-and-sealants-global-market-report

Waterproofing Chemicals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/waterproofing-chemicals-global-market-report

Water Infrastructure Repair Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/water-infrastructure-repair-technologies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795